| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.3 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.3 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.069 | 0.3 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |